Trousseau syndrome due to pleural mesothelioma

Neurologist

Volumn 13, Issue 4, 2007, Pages 205-208

  Matsui, Hideaki ^a   Nishinaka, Kazuto ^a   Oda, Masaya ^a   Kubori, Tamotsu ^a   Udaka, Fukashi ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

Brain infarction; Pleural mesothelioma; Trousseau syndrome

Indexed keywords

HEPARIN CALCIUM;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD EXAMINATION; BRAIN INFARCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GRAND MAL SEIZURE; HOSPITAL ADMISSION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PLEURA THICKENING; PRIORITY JOURNAL; SPUTUM; THORAX RADIOGRAPHY; THROMBOSIS; TROUSSEAU SYNDROME;

AGED; BRAIN INFARCTION; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MESOTHELIOMA; PLEURAL NEOPLASMS; VENOUS THROMBOSIS;

EID: 34447324137     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000253113.53846.ec     Document Type: Article

References (15)

1. Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. J Clin Invest. 1981;67:1665-1671.
2. Gordon SG, Franks JJ, Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res. 1975;6:127-137.
3. Donati MB. Cancer and thrombosis: from phlegmasia alba dolens to transgenic mice. Thromb Haemost. 1995;74:278-281.
4. Rogers JS 2nd, Murgo AJ, Fontana JA, et al. Chemotherapy for breast cancer decreases plasma protein C and protein S. J Clin Oncol. 1988;6:276-281.
5. O'Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2:689-692.
6. Bastida E, Ordinas A. Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation. Haemostasis. 1988;18:29-36.
7. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood. 1983;62:14-31.
8. Zhang Y, Deng Y, Luther T, et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 1994;94:1320-1327.
9. Warren BA, Vales O. The adhesion of thromboplastic tumour emboli to vessel walls in vivo. Br J Exp Pathol. 1972;53:301-313.
10. Shimizu Y, Uchiyama S, Mori G, et al. A young patient with endometrioid adenocarcinoma who suffered Trousseau's syndrome associated with vasculitis [in Japanese'. Rinsho Shinkeigaku. 2002;42:227-232.
11. Uchiyama S, Shimizu Y. Brain infarction seen in patients with malignant tumors (Trousseau's syndrome) [in Japanese]. Shinkeinaika. 2003;58:463-467.
12. Chaturvedi S, Ansell J, Recht L. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke. 1994;25:1215-1218.
13. Farmer CK, Goldsmith DJ. Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma. Postgrad Med J. 2001;77:333-334.
14. Tucker SC, Coulson IH, Salman W, et al. Mesothelioma-associated antiphospholipid antibody syndrome presenting with cutaneous infarction and neuropathy. Br J Dermatol. 1998;138:1092-1094.
15. Lecumberri R, Paramo JA, Rocha E. Anticoagulant treatment and survival in cancer patients: the evidence from clinical studies. Haematologica. 2005;90:1258-1266.